A Phase 3 Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Maintenance Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT-Maintenance Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sandborn, William
  • Feagan, Brian
  • Marano, Colleen
  • Strauss, Richard
  • Johanns, Jewel
  • Zhang, Hongyan
  • Guzzo, Cynthia
  • Colombel, Jean-Frederic
  • Reinisch, Walter
  • Gibson, Peter
  • Collins, Judy
  • Jarnerot, Gunnar
  • Rutgeerts, Paul

publication date

  • October 1, 2012